{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:42:57Z","timestamp":1790206977127,"version":"4.1.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1371,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1111\/j.1442-2050.2011.01285.x","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T11:33:03Z","timestamp":1322825583000},"page":"535-544","source":"Crossref","is-referenced-by-count":14,"title":["Meta-analysis: risk of esophageal adenocarcinoma with medications which relax the lower esophageal sphincter"],"prefix":"10.1093","volume":"25","author":[{"given":"L.","family":"Alexandre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Broughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. L. P.","family":"Beales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,11,30]]},"reference":[{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2","article-title":"Changing patterns in the incidence of esophageal and gastric carcinoma in the United States","volume":"83","author":"Devesa","year":"1998","journal-title":"Cancer"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.1991.03460100089030","article-title":"Rising incidence of adenocarcinoma of the esophagus and gastric cardia","volume":"265","author":"Blot","year":"1991","journal-title":"JAMA"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5694\/j.1326-5377.2009.tb02813.x","article-title":"Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972-2005","volume":"191","author":"Stavrou","year":"2009","journal-title":"Med J Aust"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjc.6605246","article-title":"Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005","volume":"101","author":"Cook","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB5|cit5","first-page":"669","article-title":"Trends in incidence of oesophageal and stomach cancer subtypes in Europe","volume":"22","author":"Steevens","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1111\/j.1572-0241.2008.02191.x","article-title":"Continuing rapid increase in esophageal adenocarcinoma in England and Wales","volume":"103","author":"Lepage","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1155\/2006\/175751","article-title":"Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada - an epidemiological study from 1964-2002","volume":"20","author":"Parfitt","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/02841860701403046","article-title":"Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences","volume":"46","author":"Falk","year":"2007","journal-title":"Acta Oncol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-540-70579-6_1","article-title":"Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third","volume":"182","author":"Vial","year":"2010","journal-title":"Recent Results Cancer Res"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10552-004-3485-7","article-title":"Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study","volume":"16","author":"Lindblad","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/jnci\/djg047","article-title":"Population attributable risks of esophageal and gastric cancers","volume":"95","author":"Engel","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-133-3-200008010-00007","article-title":"Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma","volume":"133","author":"Lagergren","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB14|cit14","first-page":"749","article-title":"Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux","volume":"7","author":"Vaughan","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF01831386","article-title":"Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States)","volume":"5","author":"Wang","year":"1994","journal-title":"Cancer Causes Control"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1365-2036.1997.00241.x","article-title":"Effects of 3-days' intake of a sustained-release preparation of the nitric oxide donor, isosorbide dinitrate, on oesophageal motility","volume":"11","author":"Stacher","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00004836-198708000-00006","article-title":"The effect of terbutaline sulfate, nitroglycerin, and aminophylline on lower esophageal sphincter pressure and radionuclide esophageal emptying in patients with achalasia","volume":"9","author":"Wong","year":"1987","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000171324","article-title":"Effects of pirenzepine and atropine on basal lower esophageal pressure and gastric acid secretion in man: a placebo-controlled randomized study","volume":"9","author":"Aggestrup","year":"1991","journal-title":"Dig Dis"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0016-5085(82)80062-0","article-title":"Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation","volume":"83","author":"Gelfond","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/BF01391441","article-title":"Effect of an oral beta2-adrenergic agonist on lower esophageal sphincter pressure in normals and in patients with achalasia","volume":"27","author":"DiMarino","year":"1982","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0091-6749(81)90087-7","article-title":"Effect of theophylline on gastroesophageal reflux in normal adults","volume":"67","author":"Berquist","year":"1981","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB22|cit22","first-page":"127","article-title":"Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study","volume":"73","author":"Rushnak","year":"1980","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/gut.39.1.5","article-title":"Oesphageal cancer is an uncommon cause of death in patients with Barrett's oesophagus","volume":"39","author":"van de Burgh","year":"1996","journal-title":"Gut"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cgh.2007.05.022","article-title":"Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers","volume":"5","author":"Fortuny","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000097947","article-title":"Non-steroidal anti-inflammatory drugs, lower oesophageal sphincter-relaxing drugs and oesophageal cancer. A case-control study","volume":"74","author":"Ranka","year":"2006","journal-title":"Digestion"},{"issue":"1","key":"10.1111\/j.1442-2050.2011.01285.x-BIB26|cit26","first-page":"MR000006","article-title":"Publication bias in clinical trials due to statistical significance or direction of trial results","author":"Hopewell","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjc.6604880","article-title":"Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis","volume":"100","author":"Abnet","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1572-0241.2006.00539.x","article-title":"Barrett's esophagus and medications that relax the lower esophageal sphincter","volume":"101","author":"Corley","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1136\/gut.2005.066043","article-title":"Nitrate and nitrosative chemistry within Barrett's oesophagus during acid reflux","volume":"54","author":"Suzuki","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/carcin\/bgq130","article-title":"Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinoma","volume":"31","author":"Clemons","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2007.06.061","article-title":"Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms","volume":"133","author":"Clemons","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB32|cit32","first-page":"3037","article-title":"Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide","volume":"62","author":"Liu","year":"2002","journal-title":"Cancer Res"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1152\/physrev.00004.2008","article-title":"Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?","volume":"88","author":"Wallace","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/scdb.2000.0211","article-title":"Calcium signalling - an overview","volume":"12","author":"Bootman","year":"2001","journal-title":"Semin Cell Dev Biol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ceca.2007.03.006","article-title":"T-type Ca2+ channel expression in human esophageal carcinomas: a functional role in proliferation","volume":"43","author":"Lu","year":"2008","journal-title":"Cell Calcium"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/14728221003733602","article-title":"Targeting TRPC6 channels in oesophageal carcinoma growth","volume":"14","author":"Ding","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/mc.20201","article-title":"Correlation of visinin-like-protein-1 expression with clinicopathological features in squamous cell carcinoma of the esophagus","volume":"45","author":"Wickborn","year":"2006","journal-title":"Mol Carcinog"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB38|cit38","first-page":"13163","article-title":"A mechanism for P-gycloprotein-mediated apoptosis as revealed by verapamil hypersensitivity","volume":"42","author":"Kawatsky","year":"2003","journal-title":"Biochemistry"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB39|cit39","first-page":"1027","article-title":"Apoptosis of human primary and metastatic colon adenocarcinoma cell lines in vitrol induced by 5-fluorouracil, verapamil, and hyperthermia","volume":"14","author":"Shchepotin","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2093::AID-CNCR1>3.0.CO;2-E","article-title":"Effects of calcium channel blockers on cellular apoptosis: implications for carcinogenic potential","volume":"85","author":"Mason","year":"1999","journal-title":"Cancer"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-007-9135-0","article-title":"Medication use and the risk of breast cancer","volume":"22","author":"Davis","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/cncr.11663","article-title":"Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years","volume":"98","author":"Li","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-005-9091-x","article-title":"A cohort study of antihypertensive medication use and breast cancer among Danish women","volume":"97","author":"Fryzek","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archinte.160.3.349","article-title":"Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer","volume":"160","author":"Meier","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1055-9965.EPI-03-0093","article-title":"Inverse association between prostate cancer and the use of calcium channel blockers","volume":"13","author":"Debes","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0959-8049(02)00157-0","article-title":"Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study","volume":"39","author":"Beiderbeck-Noll","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G","article-title":"Cancer risk and mortality in users of calcium channel blockers. A cohort study","volume":"89","author":"Sorensen","year":"2000","journal-title":"Cancer"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.bjc.6601125","article-title":"Ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in oesophageal cancer cells: involvement of the p38MAPK signalling pathway","volume":"89","author":"Sutter","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ijc.10724","article-title":"Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells","volume":"102","author":"Sutter","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2174\/138945010792006807","article-title":"Tyrosine kinse coupled receptor transactivation associated to G protein coupled receptors","volume":"11","author":"Almendro","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"16379","DOI":"10.1074\/jbc.M006617200","article-title":"Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinses and induce apoptosis","volume":"279","author":"Seelars","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1442-2050.2011.01285.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/978-3-642-13443-2_18","article-title":"Methyxanthine and inflammatory cells","volume":"200","author":"Hasko","year":"2011","journal-title":"Handb Exp Pharmacol"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-2050.2011.01285.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/dote\/article-pdf\/25\/6\/535\/10396797\/dote0535.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T04:07:45Z","timestamp":1593317265000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article-lookup\/doi\/10.1111\/j.1442-2050.2011.01285.x"}},"subtitle":["Esophageal cancer and LES-relaxing drugs"],"short-title":[],"issued":{"date-parts":[[2011,11,30]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1442-2050.2011.01285.x","relation":{},"ISSN":["1120-8694"],"issn-type":[{"value":"1120-8694","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,30]]}}}